FGF19 and hepatocellular carcinoma: PNETs overexpressing FGFR4 exhibit an increased propensity for forming hepatic metastases in mice [29] and hepatocellular carcinoma in humans is associated with excessive FGFR4-FGF19 signaling [31,35].